Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries?

References

• de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846–52
   PubMed Web of Science ®Google Scholar
• de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992; 15: 256–61
   PubMedGoogle Scholar
• de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167–76
   PubMed Web of Science ®Google Scholar
• Schneider B, Emre S, Groszmann R, Karani J, McKiernan P, Sarin S, et al. Expert pediatric opinion on the report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 2006; 10: 893–907
   PubMedGoogle Scholar
• Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding: unresolved issues. Summary of an American association for the study of liver diseases and European association for the study of the liver single-topic conference. Hepatology 2008; 47: 1764–72
   PubMedGoogle Scholar
• Karsan HA, Morton SC, Shekelle PG, Spiegel BM, Suttorp MJ, Edelstein MA, et al. Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis. Dig Dis Sci 2005; 50: 399–406
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Zamora J, Gomez-Camarero J, Molinero LM, Banares R, Albillos A. Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008; 149: 109–22
   PubMed Web of Science ®Google Scholar
• Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005; 21: 347–61
   PubMedGoogle Scholar
• Tripathi D, Graham C, Hayes PC. Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis. Eur J Gastroenterol Hepatol 2007; 19: 835–45
   PubMed Web of Science ®Google Scholar
• Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 2004; 39: 858–63
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir SA, Olsson R, Bjornsson ES. Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994–1999. Scand J Gastroenterol 2005; 40: 1462–8
   PubMed Web of Science ®Google Scholar
• Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjoro K, et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007; 42: 1501–8
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Andersen PK, Lash TL, Sorensen HT. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology 2008; 48: 214–20
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Sorensen HT. Alcoholic cirrhosis in Denmark – population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol 2008; 8: 3
   PubMed Web of Science ®Google Scholar
• Stokkeland K, Brandt L, Ekbom A, Osby U, Hultcrantz R. Morbidity and mortality in liver diseases in Sweden –2001 in relation to alcohol consumption. Scand J Gastroenterol ;41 1969; 2006: 459–64
   Google Scholar
• Simpura J, Tigerstedt C, Hanhinen S, Lagerspetz M, Leifman H, Moskalewicz J, et al. Alcohol misuse as a health and social issue in the Baltic Sea region. A summary of findings from the Baltica Study. Alcohol Alcohol 1999; 34: 805–23
   PubMed Web of Science ®Google Scholar
• Skinhoj P, Prytz H. Changing mortality from cirrhosis in Denmark 1965–1978. Scand J Gastroenterol 1981; 16: 833–7
   PubMed Web of Science ®Google Scholar
• Prytz H, Skinhoj P. Morbidity, mortality, and incidence of cirrhosis in Denmark –1978. Scand J Gastroenterol ;16 1976; 1981: 839–44
   Google Scholar
• Ludviksdottir D, Skulason H, Jakobsson F, Thorisdottir A, Cariglia N, Magnusson B, et al. Epidemiology of liver cirrhosis morbidity and mortality in Iceland. Eur J Gastroenterol Hepatol 1997; 9: 61–6
   PubMed Web of Science ®Google Scholar
• Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991; 13: 650–5
   PubMed Web of Science ®Google Scholar
• D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19: 475–505
   PubMed Web of Science ®Google Scholar
• Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–9
   PubMed Web of Science ®Google Scholar
• Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology 2006; 43: 500–5
   PubMed Web of Science ®Google Scholar
• Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652–9
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: the modern management of portal hypertension: primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther 2008; 28: 178–86
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 526–35
   PubMedGoogle Scholar
• Gluud, LL, Klingenberg, S, Nikolova, D, Gluud, C. Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol 2007;102:2842–8; quiz 2841, 2849.
   PubMed Web of Science ®Google Scholar
• Tiani C, Abraldes JG, Bosch J. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding. Dig Liver Dis 2008; 40: 318–27
   PubMedGoogle Scholar
• Schmitz RJ, Sharma P, Badr AS, Qamar MT, Weston AP. Incidence and management of esophageal stricture formation, ulcer bleeding, perforation, and massive hematoma formation from sclerotherapy versus band ligation. Am J Gastroenterol 2001; 96: 437–41
   PubMedGoogle Scholar
• Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123: 280–7
   PubMed Web of Science ®Google Scholar
• Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey – the case for nonselective beta blockers. Gastroenterology 2007; 133: 2029–36
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC, Morillas R, Banares R, Albillos A, Villanueva C, Vila C, et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003; 37: 1260–6
   PubMed Web of Science ®Google Scholar
• D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599–612
   PubMed Web of Science ®Google Scholar
• Bendtsen F, Krag A, Moller S. Treatment of acute variceal bleeding. Dig Liver Dis 2008; 40: 328–36
   PubMedGoogle Scholar
• de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 1999; 19: 439–55
   PubMed Web of Science ®Google Scholar
• Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29: 1655–61
   PubMed Web of Science ®Google Scholar
• D'Amico G, Luca A. TIPS is a cost-effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varices. J Hepatol 2008; 48: 387–90
   PubMedGoogle Scholar
• Garcia-Pagan JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. Semin Liver Dis 1999; 19: 427–38
   PubMedGoogle Scholar
• D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003; 124: 1277–91
   PubMed Web of Science ®Google Scholar
• Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, Gonzalez Abraldes J, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004; 127: 1123–30
   PubMed Web of Science ®Google Scholar
• Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology 2008; 47: 1604–1614
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003; 17: 53–64
   PubMed Web of Science ®Google Scholar
• Ioannou, G, Doust, J, Rockey, DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003: CD002147.
   PubMedGoogle Scholar
• Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990; 99: 1388–95
   PubMed Web of Science ®Google Scholar
• Gotzsche, PC, Hrobjartsson, A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev 2005: CD000193.
   PubMedGoogle Scholar
• Laine L, el-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119: 1–7
   PubMed Web of Science ®Google Scholar
• Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060–4
   PubMed Web of Science ®Google Scholar
• Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc 2008; 22: 2149–52
   PubMedGoogle Scholar
• Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361: 952–4
   PubMed Web of Science ®Google Scholar
• Bleichner G, Boulanger R, Squara P, Sollet JP, Parent A. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986; 73: 724–6
   PubMedGoogle Scholar
• Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20: 34–8
   PubMed Web of Science ®Google Scholar
• Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108: 1828–34
   PubMed Web of Science ®Google Scholar
• Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24: 802–6
   PubMedGoogle Scholar
• Vivas S, Rodriguez M, Palacio MA, Linares A, Alonso JL, Rodrigo L. Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci 2001; 46: 2752–7
   PubMed Web of Science ®Google Scholar
• Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004; 39: 746–53
   PubMed Web of Science ®Google Scholar
• Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27: 1207–12
   PubMed Web of Science ®Google Scholar
• Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5: 463–7
   PubMed Web of Science ®Google Scholar
• Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267–72
   PubMed Web of Science ®Google Scholar
• Hsieh WJ, Lin HC, Hwang SJ, Hou MC, Lee FY, Chang FY, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93: 962–6
   PubMed Web of Science ®Google Scholar
• Soares-Weiser, K, Brezis, M, Tur-Kaspa, R, Leibovici, L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002: CD002907.
   Google Scholar
• Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922–38
   PubMed Web of Science ®Google Scholar
• Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000; 46(Suppl 3–4)I1–15
   PubMedGoogle Scholar
• Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140–8
   PubMed Web of Science ®Google Scholar
• Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 1998; 26: 1066–70
   PubMed Web of Science ®Google Scholar
• Aparicio JR, Such J, Pascual S, Arroyo A, Plazas J, Girona E, et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999; 31: 277–83
   PubMed Web of Science ®Google Scholar
• Fernandez, J, Ruiz del Arbol, L, Gomez, C, Durandez, R, Serradilla, R, Guarner, C, , et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006;131:1049–56; quiz 1285.
   PubMed Web of Science ®Google Scholar
• Conn HO. Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology 1993; 17: 148–58
   PubMed Web of Science ®Google Scholar
• LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187: 413–20
   PubMed Web of Science ®Google Scholar
• Jalan R, Gooday R, O'Carroll RE, Redhead DN, Elton RA, Hayes PC. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J Hepatol 1995; 23: 697–705
   PubMedGoogle Scholar
• Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192–7
   PubMed Web of Science ®Google Scholar
• Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89: 1520–2
   PubMed Web of Science ®Google Scholar
• Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386–400
   PubMed Web of Science ®Google Scholar
• McAvoy NC, Hayes PC. The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage. Eur J Gastroenterol Hepatol 2006; 18: 1135–41
   PubMedGoogle Scholar
• Ferguson JW, Hayes PC. Transjugular intrahepatic portosystemic shunt in the prevention of rebleeding in oesophageal varices. Eur J Gastroenterol Hepatol 2006; 18: 1167–71
   PubMedGoogle Scholar
• Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol 2007; 41(Suppl 3)S344–51
   Google Scholar
• Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138–46
   PubMedGoogle Scholar
• Patch D, Nikolopoulou V, McCormick A, Dick R, Armonis A, Wannamethee G, Burroughs A. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998; 28: 454–60
   PubMedGoogle Scholar
• Banares R, Casado M, Rodriguez-Laiz JM, Camunez F, Matilla A, Echenagusia A, et al. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998; 93: 75–9
   PubMedGoogle Scholar
• Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138–44
   PubMed Web of Science ®Google Scholar
• Azoulay D, Castaing D, Majno P, Saliba F, Ichai P, Smail A, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35: 590–7
   PubMedGoogle Scholar
• Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol 2002; 37: 703–4
   PubMedGoogle Scholar
• Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?. J Hepatol 2001; 35: 658–60
   PubMed Web of Science ®Google Scholar
• Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40: 793–801
   PubMed Web of Science ®Google Scholar
• Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981–7
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JEA. An early decision for PTFE-TIPS improves survival in high risk cirrhotic patients admitted with an acute variceal bleeding. A multicenter RCT. Hepatology 2008; 48: 337A
   Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864–71
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464–70
   PubMed Web of Science ®Google Scholar
• L PR Laine, Nevens, F, Banares, R, Patch, D, Bosch, J. Portal hypertension. Proc of the Fourth Baveno International Consensus Workshop on methodology of diagnosis and treatment. Malden Massachusetts: Blackwell Publishing; 2006.
   Google Scholar
• Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30: 612–22
   PubMedGoogle Scholar